Last update 25 Nov 2024
Nanjing KAEDI Biotherapeutics Co, Ltd.

Nanjing KAEDI Biotherapeutics Co, Ltd.

Private Company|
2020|
Jiangsu Sheng, China
|
www.kaedibio.com

Overview

Tags

Neoplasms
Immune System Diseases
Infectious Diseases
Bispecific antibody
Nanobody
Autologous CAR-T

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Neoplasms4
Immune System Diseases2
Infectious Diseases2
Nervous System Diseases1
Hemic and Lymphatic Diseases1
Top 5 Drug TypeCount
Bispecific antibody2
Nanobody1
Autologous CAR-T1
Top 5 TargetCount
CD33(Myeloid cell surface antigen CD33)2
NKG2D(NKG2-D type II integral membrane protein)1
CLDN18.2(Claudin 18.2)1

Related

4
Drugs associated with Nanjing KAEDI Biotherapeutics Co, Ltd.
KD-025(Nanjing Kaedi Biotechnology Co Ltd)
Target
NKG2D
Mechanism
NKG2D antagonists
Active Org.
Nanjing KAEDI Biotech, Inc.Nanjing KAEDI Biotech, Inc. [+1]
Originator Org.
Nanjing KAEDI Biotech, Inc.Nanjing KAEDI Biotech, Inc.
Active Indication
Glioblastoma [+2]
Inactive Indication-
Drug Highest PhasePhase 1/2
First Approval Ctry. / Loc.-
First Approval Date-
CN114195898
Patent Mining
Target
CD33
Mechanism-
Active Org.
Nanjing KAEDI Biotherapeutics Co, Ltd.Nanjing KAEDI Biotherapeutics Co, Ltd.
Originator Org.
Nanjing KAEDI Biotherapeutics Co, Ltd.Nanjing KAEDI Biotherapeutics Co, Ltd.
Active Indication
Hemic and Lymphatic Diseases [+1]
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
CN114702596
Patent Mining
Target
CD33
Mechanism-
Active Org.
Nanjing KAEDI Biotherapeutics Co, Ltd.Nanjing KAEDI Biotherapeutics Co, Ltd.
Originator Org.
Nanjing KAEDI Biotherapeutics Co, Ltd.Nanjing KAEDI Biotherapeutics Co, Ltd.
Active Indication
Immune System Diseases [+2]
Inactive Indication-
Drug Highest PhaseDiscovery
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Nanjing KAEDI Biotherapeutics Co, Ltd.
Login to view more data
0 Patents (Medical) associated with Nanjing KAEDI Biotherapeutics Co, Ltd.
Login to view more data
100 Deals associated with Nanjing KAEDI Biotherapeutics Co, Ltd.
Login to view more data
100 Translational Medicine associated with Nanjing KAEDI Biotherapeutics Co, Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
3
1
Phase 2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
KD-025(Nanjing Kaedi Biotechnology Co Ltd)
 ( NKG2D )		NKG2DL Positive Solid Tumors
More
IND Approval
CN114702596
 ( CD33 )Patent Mining		Neoplasms
More
Discovery
CN113896801
 ( CLDN18.2 )Patent Mining		Neoplasms
More
Discovery
CN114195898
 ( CD33 )Patent Mining		Hemic and Lymphatic Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free